Editor

Lario Therapeutics Secures $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

Lario Therapeutics, a pioneering biopharmaceutical firm dedicated to advancing precision medicines for epileptic and neurological disorders, has been awarded a substantial $6 million USD grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is earmarked to propel Lario’s preclinical research into CaV2.3 calcium channel inhibitors, heralded as a novel approach to…

Read More

Juno Secures $8.5 Million to Expand Child Disability Insurance for Working Parents

Juno, a trailblazer in the realm of child disability insurance in the U.S., has announced a significant milestone with the closure of an $8.5 million Series A funding round led by Spero Ventures, alongside contributions from Floating Point, Newark Ventures, and WVV Capital. This latest infusion of capital brings Juno’s total raised funds to $12.5…

Read More

EdgeRunner AI Launches with $5.5M Seed Funding to Pioneer Generative AI for Edge Devices

EdgeRunner AI, a trailblazing startup focused on developing Generative AI solutions for edge computing environments, has emerged from stealth mode with the announcement of a $5.5 million seed funding round. The investment, led by Four Rivers Group and supported by Madrona Ventures and strategic angels, positions EdgeRunner AI at the forefront of transforming how enterprises…

Read More

REMspace Secures $1M Seed Round to Propel Lucid Dreaming Innovation

REMspace, a pioneering neurotechnology firm dedicated to advancing the practice of lucid dreaming, has successfully closed a $1 million seed funding round. The investment, raised from prominent lucid dreaming practitioners and enthusiasts across Europe, positions REMspace to accelerate its mission of making lucid dreaming accessible on a global scale. Led by CEO Michael Raduga, REMspace…

Read More

After.com Secures $10 Million Series A Funding to Expand Innovative End-of-Life Services Platform

After.com, a trailblazing online platform revolutionizing end-of-life services, announced today the successful closure of its Series A funding round, raising $10 million. The investment was spearheaded by HIPstr, the early-stage investment arm of HighPost Capital, LLC, underscoring a significant endorsement of After.com’s pioneering approach in the death care industry. Founded in 2020, After.com has swiftly…

Read More

Thoughtful AI Launches Human-Capable AI Agents, Secures $20M in Series A Funding

Thoughtful AI, a frontrunner in AI-powered revenue cycle automation, has marked a significant leap forward with the introduction of groundbreaking AI Agents designed to revolutionize healthcare revenue cycle management (RCM). The company also announced the successful closure of a $20 million Series A funding round led by Nick Solaro of Drive Capital, with participation from…

Read More

Allium Secures $16.5 Million Series A Funding to Enhance Enterprise Blockchain Solutions

Allium, a pioneering blockchain data platform catering to enterprise needs, has announced the successful closure of a $16.5 million Series A funding round. The investment, spearheaded by Theory Ventures and supported by seed investors Kleiner Perkins and Amplify Partners, brings Allium’s total capital raised to $21.5 million. Founded with a mission to simplify the complexities…

Read More

Xapien Secures $10 Million in Series A Funding to Propel AI-Powered Transformation of Research Industry

Xapien, a leader in AI-driven due diligence, announced today the successful closure of its $10 million Series A funding round led by YFM Equity Partners. This latest round brings Xapien’s total funding to $17.8 million and underscores its commitment to revolutionizing the global compliance market with advanced technology. Xapien specializes in transforming due diligence processes…

Read More

CultureAI Secures $10 Million to Enhance Human Risk Management Solutions

CultureAI, a leading Human Risk Management Platform, announced today the successful closure of a $10 million Series A funding round. Mercia Ventures and Smedvig Ventures co-led the investment, with continued support from existing investors Passion Capital and Senovo. This financing marks a significant milestone for CultureAI, fueling its mission to revolutionize how organizations mitigate human…

Read More

Ancilia Biosciences Secures $4.2 Million in Financing to Advance CRISPR-Based Bacterial Therapies

Ancilia Biosciences, a pioneering biotechnology firm specializing in harnessing CRISPR technology for bacterial therapies, announced today the successful closure of an $4.2 million financing round. Safar Partners led the investment, joined by Metaplanet, Psymed Ventures, Zubi Capital, Spacecadet Ventures, and other institutional and private investors. The funding underscores the company’s commitment to leveraging CRISPR’s natural…

Read More